Abbvie Announces New Formulary Listings For Skyrizi In The Treatment Of Moderate To Severe Plaque Psoriasis; Manitoba Lists Skyrizi On Its Provincial Formulary Effective Mar 02, Non-Insured Health Benefits Program Lists Skyrizi On Its Formulary